Tag: rare metabolic disease gene therapy eligibility
Pompe Disease Gene Therapy 2024: FDA Approval Status, Cost With Insurance, Long-Term Efficacy & Eligibility Guide
Per March 2024 FDA, CDC, and National Organization for Rare Disorders (NORD) data, no Pompe disease gene therapy has full US approval yet, with 3 active phase 1/2 trials open for eligible patients right now. This 2024 buying guide breaks down premium FDA-vetted gene therapy vs counterfeit unregulated overseas models, including the latest approval timelines,